SRC and cancer: Hyperaction of c-Src has been importantly implicated in pancreatic cancer progression [39], the positive impacts of c-Src-mediated DMAP1 pY246 on tumour growth exemplifies that the adaption of cancer cells to mitotic defect-induced stress is addicted to strong c-Src activity.